Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue | $8.1M | $3.3M | $10.9M | $9.4M | $10.3M | $8.1M |
| Cost of revenue | $4.2M | $2.9M | $4.5M | $4.5M | $3.0M | $2.0M |
| Gross profit | $3.9M | $337.1K | $6.4M | $4.9M | $7.2M | $6.1M |
| Gross margin | 48.5% | 10.3% | 58.7% | 51.9% | 70.5% | 75.5% |
| R&D | $9.7M | $7.6M | $14.4M | $16.8M | $20.2M | $11.5M |
| Operating income | −$23.0M | −$20.9M | −$34.8M | −$32.8M | −$33.2M | −$19.8M |
| EBITDA | −$29.9M | −$46.0M | −$232.5M | −$25.1M | −$25.1M | −$12.0M |
| Net income | −$32.1M | −$48.3M | −$235.0M | −$28.1M | −$28.1M | −$15.3M |
| Net margin | -395.6% | -1480.1% | -2164.9% | -297.8% | -273.9% | -188.2% |
| EPS (diluted) | -0.06 | -0.09 | -0.45 | -0.06 | -0.06 | -0.03 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $17M | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $22M | $0.00 | $0.00–$0.00 | 0 |
| 2028 | $86M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
BRONCUS HLDG CORP
No one on the platform currently holds BRNHF.
No tracked institution reports a position in BRNHF as of their last filing.
No one on the platform has traded BRNHF yet.
| $85M |
| — |
| CMXCCell MedX Corp. | $0.42 | — | $126M | — |
| COLRFChina Medical & HealthCare Group Limited | $0.08 | +0.00% | $123M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.